Nov 2023 $13 M No. 7 $10 to $50 million 13
Windgap Medical, Inc.: Raise no. 7, Nov 2023 × Investors in this round 13 investors had bought by the notice of Jan 26, 2026: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $17 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Aaron Reading Mann · Executive Officer, Director Anthony Reading Watson · Executive Officer Jason Reading Durkin · Executive Officer John Reading Cadigan · Executive Officer Max Reading Meehan · Executive Officer Brent Reading Buchine · Director John Reading Wilson · Director Richard Russell · Director Timothy Reading Krochuk · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Aaron Mann, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 26, 2026. Read the notice at the SEC .
debt, options SEC Aug 2021 $39 M No. 6 $10 to $50 million 46
Windgap Medical, Inc.: Raise no. 6, Aug 2021 × Investors in this round 46 investors had bought by the notice of Jan 25, 2022: 46 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $39 M of $42 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brent Buchine · Executive Officer, Director Christopher Stepanian · Executive Officer, Director John Conley · Director John Reading Wilson · Director Michael Reading Huang · Director Richard Reading Russell · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher Stepanian, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jan 25, 2022. Read the notice at the SEC .
equity SEC Jan 2019 $12 M No. 5 $10 to $50 million 106
Windgap Medical, Inc.: Raise no. 5, Jan 2019 × Investors in this round 106 investors had bought by the notice of Jan 17, 2019: 106 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $39 M offered; $27 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brent Buchine · Executive Officer, Director Christopher Stepanian · Executive Officer, Director J. Melville Engle · Director John Melville Conley · Director John Reading Wilson · Director Richard Melville Gabriel · Director Tim Melville Krochuk · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 17, 2019. Read the notice at the SEC .
equity SEC May 2017 $4 M No. 4 $2 to $10 million 75
Windgap Medical, Inc.: Raise no. 4, May 2017 × Investors in this round 75 investors had bought by the notice of Jul 9, 2018: 75 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brent Buchine · Executive Officer, Director Christopher Stepanian · Executive Officer, Director J. Melville Engle · Director John Melville Conley · Director Richard Melville Gabriel · Director Tim Melville Krochuk · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 9, 2018. Read the notice at the SEC .
debt, options SEC Mar 2016 $3 M No. 3 $2 to $10 million 46
Windgap Medical, Inc.: Raise no. 3, Mar 2016 × Investors in this round 46 investors had bought by the notice of Apr 8, 2016: 46 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brent Buchine · Executive Officer, Director Christopher Stepanian · Executive Officer, Director J. Melville Engle · Director John Melville Conley · Director Richard Melville Gabriel · Director Tim Melville Krochuk · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 8, 2016. Read the notice at the SEC .
debt, options SEC May 2015 $4 M No. 2 $2 to $10 million 92
Windgap Medical, Inc.: Raise no. 2, May 2015 × Investors in this round 92 investors had bought by the notice of Aug 24, 2015: 92 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $0 M still to sell
Smallest investment taken $4,200
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $465,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brent Buchine · Executive Officer, Director Christopher Stepanian · Executive Officer, Director Tim Melville Krochuk · Executive Officer J. Melville Engle · Director John Melville Conley · Director Richard Melville Gabriel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “The issuer expects to pay approximately $465,000 of the gross proceeds to related persons as compensation, including the provision of benefits, over the course of eighteen (18) months.”Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Aug 24, 2015. Read the notice at the SEC .
equity SEC Apr 2014 $1 M No. 1 Under $2 million 56
Windgap Medical, Inc.: Raise no. 1, Apr 2014 × Investors in this round 56 investors had bought by the notice of Apr 24, 2014: 56 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $1 M still to sell
Smallest investment taken $10,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $362,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Brent Buchine · Executive Officer, Director Christopher Stepanian · Executive Officer, Director J. Melville Engle · Director John Melville Conley · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “The issuer expects to pay approximately $362,000 of the gross proceeds to related persons as compensation, including the provision of benefits.”Signed by Christopher Stepanian, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2014. Read the notice at the SEC .
equity SEC